Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM

Anna B Loveland1, Egor Svidritskiy1, Denis Susorov1

  • 1RNA Therapeutics Institute, UMass Chan Medical School, 368 Plantation Street, Worcester, MA, 01605, USA.

Insights

Toxic dipeptide-repeat proteins from the C9ORF72 gene block ribosome function. These proteins, poly-PR and poly-GR, inhibit translation by physically obstructing the ribosomal tunnel, explaining their toxicity in neurodegenerative diseases.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genetics

Background:

  • The C9ORF72 gene mutation is the leading genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
  • Toxic dipeptide-repeat (DPR) proteins, including poly-PR and poly-GR, are produced from these expanded G4C2 repeats.
  • The mechanism by which these DPR proteins repress cellular translation and cause toxicity is not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanism by which poly-PR and poly-GR inhibit cellular translation.
  • To determine the structural basis for the toxicity of these DPR proteins in C9ORF72-associated neurodegenerative diseases.

Main Methods:

  • Utilized cryogenic electron microscopy (cryo-EM) to visualize the interaction of DPR proteins with ribosomes.
  • Assessed the peptidyl-transferase activity of ribosomes in the presence of poly-PR and poly-GR.
  • Investigated the competitive binding between DPR proteins and the known ribosomal inhibitor erythromycin.

Main Results:

  • Poly-PR and poly-GR proteins, with at least 20 repeats, inhibit ribosome peptidyl-transferase activity at nanomolar concentrations.
  • Cryo-EM revealed that these DPR proteins bind within the ribosome's polypeptide tunnel, obstructing the peptidyl-transferase center (PTC).
  • Erythromycin binding in the tunnel competed with poly-PR, restoring peptidyl-transferase activity, indicating a shared binding site.

Conclusions:

  • Poly-PR and poly-GR exert toxicity by strongly and specifically binding within the ribosomal tunnel, thereby blocking translation.
  • This study reveals the structural mechanism underlying DPR protein toxicity in C9ORF72-ALS and FTD.
  • Understanding this mechanism offers potential therapeutic targets for these devastating neurodegenerative diseases.

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.7K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
15.9K